These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4212051)

  • 1. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen.
    Mattioli M; Reichlin M
    Arthritis Rheum; 1974; 17(4):421-9. PubMed ID: 4212051
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.
    Clark G; Reichlin M; Tomasi TB
    J Immunol; 1969 Jan; 102(1):117-22. PubMed ID: 4179557
    [No Abstract]   [Full Text] [Related]  

  • 3. Character of anti-DNA antibodies in systemic lupus erythematosus.
    Cohen SA; Hughes GR; Noel GL; Christian CL
    Clin Exp Immunol; 1971 Apr; 8(4):551-61. PubMed ID: 4102680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the SM and RNAprotein (MO) systems in SLE sera.
    Mattioli M; Reichlin M
    J Immunol; 1973 May; 110(5):1318-24. PubMed ID: 4633298
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.
    Tan EM; Kunkel HG
    J Immunol; 1966 Mar; 96(3):464-71. PubMed ID: 5932578
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 1966. 96: 464-471.
    Tan EM; Kunkel HG
    J Immunol; 2006 Feb; 176(3):1297-304. PubMed ID: 16424153
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases.
    Schur PH; Stollar BD; Steinberg AD; Talal N
    Arthritis Rheum; 1971; 14(3):342-7. PubMed ID: 4998028
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
    Mattioli M; Reichlin M
    J Immunol; 1971 Nov; 107(5):1281-90. PubMed ID: 4330162
    [No Abstract]   [Full Text] [Related]  

  • 9. Microhemagglutination test for detection of antibodies to nuclear Sm and ribonucleoprotein antigens in systemic lupus erythematosus and related diseases.
    Nakamura RM; Peebles CL; Tan EM
    Am J Clin Pathol; 1978 Nov; 70(5):800-7. PubMed ID: 102182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the specificity and clinical correlation of antiribosomal antibodies in systemic lupus erythematosus sera.
    Koffler D; Miller TE; Lahita RG
    Arthritis Rheum; 1979 May; 22(5):463-70. PubMed ID: 109096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
    Stastny P; Ziff M
    N Engl J Med; 1969 Jun; 280(25):1376-81. PubMed ID: 4181609
    [No Abstract]   [Full Text] [Related]  

  • 12. Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients.
    Doré N; Synkowski D; Provost TT
    J Am Acad Dermatol; 1983 May; 8(5):611-5. PubMed ID: 6408145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The range and specificity of antinuclear antibodies in systemic lupus erythematosus.
    Alarcón-Segovia D; Fishbein E; Alcalá H; Olguín-Palacios E; Estrada-Parra S
    Clin Exp Immunol; 1970 Apr; 6(4):557-71. PubMed ID: 4097823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence and nature of precipitating antibodies in anti-DNA sera.
    Dorsch C; Barnett EV
    Clin Immunol Immunopathol; 1974 Apr; 2(3):310-21. PubMed ID: 4207865
    [No Abstract]   [Full Text] [Related]  

  • 15. The detection of antinuclear antibodies in systemic lupus erythematosus by discontinuous counterimmunoelectrophoresis (DCIE).
    Henderson M; Wallis C; Melnick JL; Gyorkey F
    Am J Clin Pathol; 1974 Jan; 61(1):66-8. PubMed ID: 4128967
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease.
    Provost TT; Razzaque A; Maddison PJ; Reichlin M
    Arthritis Rheum; 1977; 20(8):1457-63. PubMed ID: 303519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus.
    Alcover A; Molano J; Renart J; Gil-Aguado A; Nieto A; Avila J
    Arthritis Rheum; 1984 Aug; 27(8):922-8. PubMed ID: 6380505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of a precipitin reaction to an RNA-protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus.
    Reichlin M; Mattioli M
    N Engl J Med; 1972 Apr; 286(17):908-11. PubMed ID: 4622462
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity and reactivity of cytoplasmic and nucleolar antibody in SLE sera.
    Watanabe N; Fisher HM; Epstein WV
    Arthritis Rheum; 1969 Jun; 12(3):173-80. PubMed ID: 4182395
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
    Budd JJ; Moore TL; Osborn TG
    J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.